Ticker Scorecard - CRDF Basics Company: Cardiff Oncology, Inc. IPO Date: August 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $315.99M Activated in VL: True Average Daily Range Avg Daily Range: $0.20 | 4.21% Avg Daily Range (30 D): $0.16 | 3.85% Avg Daily Range (90 D): $0.17 | 4.54% Institutional Daily Volume Avg Daily Volume: .85M Avg Daily Volume (30 D): .96M Avg Daily Volume (90 D): 1.54M Trade Size Avg Trade Size (Sh.): 173 Avg Trade Size (Sh.) (30 D): 130 Avg Trade Size (Sh.) (90 D): 158 Institutional Trades Total Inst.Trades: 167 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $1.52M Avg Inst. Trade (90 D): $1.41M Avg Inst. Trade Volume: .24M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $3.22M Avg Closing Trade (30 D): $1.52M Avg Closing Trade (90 D): $1.52M Avg Closing Volume: 359.97K     News Dec 10, 2024 @ 12:20 PM Cardiff Oncology Prices Oversubscribed $40 Million... Source: Globe Newswire Dec 10, 2024 @ 11:00 AM Cardiff Oncology Announces Positive Initial Data f... Source: N/A May 29, 2024 @ 8:05 PM Cardiff Oncology to Present at the Jefferies Healt... Source: Cardiff Oncology, Inc. May 13, 2024 @ 8:05 PM Cardiff Oncology to Present at Upcoming Investor C... Source: Cardiff Oncology, Inc. May 6, 2024 @ 12:25 PM Take the Zacks Approach to Beat the Markets: Navio... Source: Santanu Roy Financials   TTM Q2 2024 Q1 2024 Basic EPS $-.25 $-.26 $-.22 Diluted EPS $-.25 $-.26 $-.22 Revenue $ .17M $ .16M $ .21M Gross Profit $ $ $ Net Income / Loss $ -11.86M $ -11.78M $ -10.01M Operating Income / Loss $ -12.6M $ -12.55M $ -10.93M Cost of Revenue $ $ $ Net Cash Flow $ -12.46M $ 6.84M $ -3M PE Ratio     Splits Feb 20, 2019:   6:1 Jun 04, 2018:   12:1 May 30, 2012:   6:1